NIH has posted some RFA announcements that are of interest to the natural products community. Specific details on each proposal focus and award mechanism can be found at http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-16-001.html (Phased Innovation Award in Exploratory Clinical Trials and Studies of Natural Products in NCCIH High Priority Research Topics R21/R33), http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-16-002.html (Exploratory Clinical Trials and Studies of [...]
Natural Products News
The officers and members of the ASP Executive Committee have submitted a letter to provide comment on a new guidance document at USPTO (http://www.uspto.gov/patents/announce/myriad-mayo.jsp), Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products (Guidance), which has implications for the patenting of natural products, derivatives and [...]
IMS-088 derivative of withaferin A, from Withania somnifera, active in TANA pathway important for the disease.
NCCAM will hold a pre-application teleconference on Monday, January 27, 2014 from 2:00 – 3:00 pm (EST) to discuss a exciting new Funding Opportunity Announcement (FOA), entitled “Center for Advancing Natural Products Innovation and Technology” (U41). For additional information about this FOA, please click on the following link: RFA-AT-14-006 (http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-14-006.html). Interested participants should contact Anita [...]
NCCAM Program Director Craig Hopp reminds the natural products research community of the Botanical Dietary Supplement Research Centers grant opportunities. More information may be obtained at http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-14-001.html
“Marilyn K. Speedie, Ph.D., dean of the University of Minnesota College of Pharmacy, is the recipient of the 2014 Remington Honor Medal, the highest honor bestowed by the American Pharmacists Association (APhA)” (http://www.pharmacy.umn.edu/news/remington/). Dr. Speedie is a long-time member of the society and former member of the ASP Executive Committee.
July 23, 2013 – “Mendel Biotechnology, Inc., and Fundación MEDINA have entered into a license collaboration that will enable Mendel to identify novel biostimulant products….”
Bill Fenical’s group has reported discovery of a novel marine bacterial product, anthracimycin, active against Bacillus anthracis and methicillin-resistant Staphylococcus aureus (Angew. Chem. Int. Ed. 2013, doi: 10.1002/anie.201302749, published online 17 June 2013). This compound, derived from marine bacteria, may represent a new class of antibacterial compounds. (Highlighted: C&ENews, 1 July 2013, p 19; Angew. Chem. [...]
United States Pharmacopeial Convention announced Monday the availability of a new compendium that “offers freely available testing standards to help ensure the quality of herbal ingredients used in traditional medicines”
“Biosortia Pharmaceuticals Creating [Anti-Cancer] Drug Discovery Opportunity with Previously Unstudied Microorganisms”May 4th, 2013
Douglas Kinghorn (PI, Ohio State University College of Pharmacy) and colleagues will work closely with Guy Carter (Biosortia Chief Scientific Officer) to discover new, active compounds with activity toward human colon and other cancers from pre-fractionated extracts from microorganism corsortia.